Venture tracks

Guido Magni joined Versant Venturesas a venture partner. He was managing director of EuroVentures Inc. and before that global head of medical sciences at Roche (SIX:ROG; OTCQX:RHHBY). Versant has $1.6 billion under management.

Maged Shenouda departed Stifel, Nicolaus & Co. where he was a managing director and senior biotechnology analyst. He joined investor relations firm Blueprint Life Science Group as a managing director and head of East Coast operations...